Innovent's No. 4 Claudin18.2 new drug starts clinical trials. Innovent Biologics has registered a Phase I clinical trial of IBI343 (registration number: NCT05458219).

2024/06/2904:11:32 science 1400

Innovent No. 4 Claudin18.2 new drug launches clinical trial

Innovent's No. 4 Claudin18.2 new drug starts clinical trials. Innovent Biologics has registered a Phase I clinical trial of IBI343 (registration number: NCT05458219). - DayDayNews

Innovent Bio has registered an IBI343 Phase I clinical trial (registration number: NCT05458219). Currently, Innovent has a total of 50 new drugs under development. In terms of ingredient categories, the TOP3 are monoclonal antibody (17 models), double antibodies (9 models) and chemical drugs (9 models). In addition, it also involves antibody fusion proteins, CAR-T etc. But there has been no ADC before, and this is Innovent’s first ADC to enter clinical practice.


For more hot information, insight analysis, research reports, live lectures... Please pay attention to [Hard Technology]
Welcome to search [Hard Technology] on all major platforms and look for accounts with blue logos!
is here to see, understand and connect with hard technology! We focus on optoelectronic chips, artificial intelligence , aerospace, new energy, smart cars, biomedicine , science and technology finance and other industries, and rely on the unique scientific and technological intelligence data owned by the scientific and technological innovation intelligence SaaS service provider Smart Bud. Advantages, work with readers to see technology trends, understand hard technology industries, and connect to the innovative future. "Hard Technology" is produced by the Smart Bud Innovation Research Center.

science Category Latest News